Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2146973
Max Phase: Preclinical
Molecular Formula: C72H118N14O10
Molecular Weight: 1339.82
Molecule Type: Protein
Associated Items:
ID: ALA2146973
Max Phase: Preclinical
Molecular Formula: C72H118N14O10
Molecular Weight: 1339.82
Molecule Type: Protein
Associated Items:
Canonical SMILES: CCCCCCCCCC[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCCN)NC(=O)[C@H](CCCCCCCCCC)NC(=O)[C@H](CCCN)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCCN)NC1=O
Standard InChI: InChI=1S/C72H118N14O10/c1-3-5-7-9-11-13-15-23-35-53-63(87)79-55(37-25-43-73)67(91)83-59(49-51-31-19-17-20-32-51)71(95)86-48-30-42-62(86)70(94)82-58(40-28-46-76)66(90)78-54(36-24-16-14-12-10-8-6-4-2)64(88)80-56(38-26-44-74)68(92)84-60(50-52-33-21-18-22-34-52)72(96)85-47-29-41-61(85)69(93)81-57(39-27-45-75)65(89)77-53/h17-22,31-34,53-62H,3-16,23-30,35-50,73-76H2,1-2H3,(H,77,89)(H,78,90)(H,79,87)(H,80,88)(H,81,93)(H,82,94)(H,83,91)(H,84,92)/t53-,54-,55-,56-,57-,58-,59+,60+,61-,62-/m0/s1
Standard InChI Key: MWYWCKIHUSNXQE-WEMYNDRUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1339.82 | Molecular Weight (Monoisotopic): 1338.9155 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Kapoerchan VV, Knijnenburg AD, Keizer P, Spalburg E, de Neeling AJ, Mars-Groenendijk RH, Noort D, Otero JM, Llamas-Saiz AL, van Raaij MJ, van der Marel GA, Overkleeft HS, Overhand M.. (2012) 'Inverted' analogs of the antibiotic gramicidin S with an improved biological profile., 20 (20): [PMID:22989907] [10.1016/j.bmc.2012.08.038] |
Source(1):